APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study.
M I E van PoelgeestKim E KortekaasH Lena C van DoornMaaike OonkHans W NijmanIngrid A BoereAnneke L EerkensAnna K L ReynersPatricia C Ewing-GrahamJoost BartTjalling BosseMarij J P WeltersJudith R KroepSjoerd H van der BurgPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
NCT05761132.
Keyphrases
- phase ii
- squamous cell carcinoma
- clinical trial
- open label
- double blind
- early stage
- placebo controlled
- phase iii
- cross sectional
- advanced non small cell lung cancer
- sentinel lymph node
- lymph node metastasis
- randomized controlled trial
- radiation therapy
- locally advanced
- lymph node
- tyrosine kinase
- neoadjuvant chemotherapy